Organigram Amends Investor Rights Agreement with BT DE Investments
Ticker: OGI · Form: 6-K · Filed: Jan 24, 2024 · CIK: 1620737
| Field | Detail |
|---|---|
| Company | Organigram Holdings INC. (OGI) |
| Form Type | 6-K |
| Filed Date | Jan 24, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: investor-rights, corporate-governance, agreement, legal-filing
TL;DR
**Organigram just updated its investor agreement with BT DE Investments, potentially shifting power dynamics.**
AI Summary
Organigram Holdings Inc. filed a 6-K on January 24, 2024, to report an Amended and Restated Investor Rights Agreement dated January 23, 2024, between Organigram and BT DE Investments Inc. This agreement, signed by CFO Greg Guyatt, updates the terms governing BT DE Investments' rights as an investor in Organigram. This matters to investors because changes in investor rights agreements can impact control, future financing, and the strategic direction of the company, potentially affecting stock valuation.
Why It Matters
This filing signals a formal update to the relationship and rights between Organigram and a significant investor, BT DE Investments Inc., which could influence future corporate governance and strategic decisions.
Risk Assessment
Risk Level: medium — While not inherently negative, changes to investor rights agreements can introduce new risks or opportunities depending on the specific terms, which are not fully detailed in this summary filing.
Analyst Insight
Investors should monitor for further details regarding the specific changes within the Amended and Restated Investor Rights Agreement, as these terms could significantly impact shareholder value and corporate control. A deeper dive into Exhibit 99.1 is warranted once available in full.
Key Players & Entities
- ORGANIGRAM HOLDINGS INC. (company) — the registrant filing the 6-K
- BT DE INVESTMENTS INC. (company) — the other party to the Amended and Restated Investor Rights Agreement
- Greg Guyatt (person) — Chief Financial Officer of Organigram Holdings Inc., who signed the filing
- January 23, 2024 (date) — date of the Amended and Restated Investor Rights Agreement
- January 24, 2024 (date) — date the 6-K filing was made public
Forward-Looking Statements
- The specific terms of the Amended and Restated Investor Rights Agreement will be scrutinized by analysts for potential impacts on Organigram's governance. (Organigram Holdings Inc.) — high confidence, target: Q1 2024
- BT DE Investments Inc. may gain or lose certain control or influence rights over Organigram's operations. (BT DE Investments Inc.) — medium confidence, target: Ongoing
FAQ
What is the primary purpose of this 6-K filing by Organigram Holdings Inc.?
The primary purpose of this 6-K filing is to report an Amended and Restated Investor Rights Agreement dated January 23, 2024, between Organigram Holdings Inc. and BT DE Investments Inc., which is included as Exhibit 99.1.
Who are the parties involved in the Amended and Restated Investor Rights Agreement?
The parties involved in the Amended and Restated Investor Rights Agreement are ORGANIGRAM HOLDINGS INC. and BT DE INVESTMENTS INC., as stated in Exhibit 99.1 of the filing.
Who signed the 6-K report on behalf of Organigram Holdings Inc. and what is their title?
The 6-K report was signed by Greg Guyatt, who holds the title of Chief Financial Officer for Organigram Holdings Inc., as indicated in the 'SIGNATURE' section of the filing.
When was the Amended and Restated Investor Rights Agreement dated?
The Amended and Restated Investor Rights Agreement is dated January 23, 2024, as specified in Exhibit 99.1 and the signature date of the filing.
Under which SEC Act is Organigram Holdings Inc. filing this report?
Organigram Holdings Inc. is filing this report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, as stated on the cover page of the Form 6-K.
Filing Stats: 209 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-01-24 17:30:11
Filing Documents
- form6k.htm (6-K) — 4KB
- exhibit99-1.htm (EX-99.1) — 231KB
- 0001062993-24-001258.txt ( ) — 237KB
From the Filing
OrganiGram Holdings Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ ] Form 40-F [ X ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] SUBMITTED HEREWITH Exhibits 99.1 Amended and Restated Investor Rights Agreement dated January 23, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ORGANIGRAM HOLDINGS INC. /s/ Greg Guyatt Greg Guyatt Chief Financial Officer Date: January 23, 2024